Last reviewed · How we verify
Trastuzumab in combination with pertuzumab
Trastuzumab in combination with pertuzumab is a Small molecule drug developed by Cancer Research UK. It is currently in Phase 2 development. Also known as: Herceptin in combination with Perjeta.
At a glance
| Generic name | Trastuzumab in combination with pertuzumab |
|---|---|
| Also known as | Herceptin in combination with Perjeta |
| Sponsor | Cancer Research UK |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer (EARLY_PHASE1)
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) (PHASE2)
- Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management (PHASE2)
- Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma (PHASE3)
- A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer (PHASE3)
- A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer (PHASE2, PHASE3)
- A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer (PHASE3)
- Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Trastuzumab in combination with pertuzumab CI brief — competitive landscape report
- Trastuzumab in combination with pertuzumab updates RSS · CI watch RSS
- Cancer Research UK portfolio CI
Frequently asked questions about Trastuzumab in combination with pertuzumab
What is Trastuzumab in combination with pertuzumab?
Trastuzumab in combination with pertuzumab is a Small molecule drug developed by Cancer Research UK.
Who makes Trastuzumab in combination with pertuzumab?
Trastuzumab in combination with pertuzumab is developed by Cancer Research UK (see full Cancer Research UK pipeline at /company/cancer-research-uk).
Is Trastuzumab in combination with pertuzumab also known as anything else?
Trastuzumab in combination with pertuzumab is also known as Herceptin in combination with Perjeta.
What development phase is Trastuzumab in combination with pertuzumab in?
Trastuzumab in combination with pertuzumab is in Phase 2.
Related
- Manufacturer: Cancer Research UK — full pipeline
- Also known as: Herceptin in combination with Perjeta
- Compare: Trastuzumab in combination with pertuzumab vs similar drugs
- Pricing: Trastuzumab in combination with pertuzumab cost, discount & access